These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12861976)

  • 1. The future of vaccines--cancer meets infectious diseases: immune mechanisms. 10-13 April 2003, Semmering, Austria.
    Olszewska W; Openshaw P
    IDrugs; 2003 Jun; 6(6):522-4. PubMed ID: 12861976
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of vaccines--cancer meets infectious diseases: cancer vaccines and emerging vaccines. 10-13 April 2003, Semmering, Austria.
    Ulmer JB
    IDrugs; 2003 Jun; 6(6):525-6. PubMed ID: 12861987
    [No Abstract]   [Full Text] [Related]  

  • 3. Decoding the human immune system to transform the future of global disease prevention and control.
    Koff WC; Schenkelberg T
    Expert Rev Vaccines; 2016 Oct; 15(10):1235-6. PubMed ID: 27010379
    [No Abstract]   [Full Text] [Related]  

  • 4. Type I interferons as vaccine adjuvants against infectious diseases and cancer.
    Bracci L; La Sorsa V; Belardelli F; Proietti E
    Expert Rev Vaccines; 2008 Apr; 7(3):373-81. PubMed ID: 18393607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine and recommended vaccinations for travellers.
    Duszczyk E; Talarek E
    Int Marit Health; 2008; 59(1-4):116-23. PubMed ID: 19227745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edward Jenner Institute for Vaccine Research--third international meeting: 12-16 April 2003, Oxford, UK.
    Williams NA
    IDrugs; 2003 Jun; 6(6):527-30. PubMed ID: 12861977
    [No Abstract]   [Full Text] [Related]  

  • 7. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is prevention of cancer possible with tumor-specific vaccines?
    Demiroğlu H
    Med Hypotheses; 1997 Sep; 49(3):281-4. PubMed ID: 9293474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field.
    Majhen D; Calderon H; Chandra N; Fajardo CA; Rajan A; Alemany R; Custers J
    Hum Gene Ther; 2014 Apr; 25(4):301-17. PubMed ID: 24580050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB; Shearer MH; Kennedy RC
    J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenomics approaches for vaccine evaluation.
    Petrizzo A; Tornesello M; Buonaguro FM; Buonaguro L
    J Immunotoxicol; 2012; 9(3):236-40. PubMed ID: 22894136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines of the future.
    Smith R; Renaud RC
    Nat Rev Drug Discov; 2003 Oct; 2(10):767-8. PubMed ID: 14579810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious diseases expected to capture headlines, attention in months ahead.
    Traynor K
    Am J Health Syst Pharm; 2005 Sep; 62(17):1748, 1750-1. PubMed ID: 16120729
    [No Abstract]   [Full Text] [Related]  

  • 16. The Sir Mark Oliphant Conferences: international frontiers of science and technology.
    Belz GT; De Groot A
    Hum Vaccin; 2008; 4(4):260-1. PubMed ID: 18682691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human and translational immunology in the third millennium: progress, challenges and opportunities.
    Galani IE; Klechevsky E; Andreakos E
    Nat Immunol; 2019 Dec; 20(12):1568-1573. PubMed ID: 31745346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prime-boost immunization strategies for infectious diseases.
    McShane H
    Curr Opin Mol Ther; 2002 Feb; 4(1):23-7. PubMed ID: 11883691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines: an historical perspective and view to the future.
    Liu MA
    Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines: A review of immune-based interventions to prevent and treat disease.
    Alemayehu D; Utt E; Knirsch C
    J Clin Pharmacol; 2015 Mar; 55 Suppl 3():S93-102. PubMed ID: 25707968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.